Materials engineers at Stanford University have developed a novel hydrogel drug delivery system that transforms daily or weekly injections of diabetes and weight control drugs like Ozempic, Mounjaro, Trulicity, Victoza, and others to just once every four months. In a new study published in Cell Reports Medicine, researchers believe that such a system will greatly improve the management of both diabetes and weight, improve patient drug compliance, and help those with type 2 diabetes improve long-term health outcomes.
Leave A Comment